Want to join the conversation?
$HCP, a fully integrated REIT serving the healthcare industry, said for 2016 HCRMC anticipates normalized EBITDAR of $577MM before the temporary impact from the pending asset sales and DoJ defense costs. After adjusting for these items, $HCP estimates 2016 EBITDAR to be $555MM, supporting the ability to meet the master lease obligations.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.